Infect Chemother.
2021 Sep;53(3):570-571. 10.3947/ic.2021.0089.
Reply: Comments on the Published Meta-Analysis of Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/Relebactam in Complicated Infections
- Affiliations
-
- 1Staten Island University Hospital, Staten Island, NY, USA
- KMID: 2521251
- DOI: http://doi.org/10.3947/ic.2021.0089
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/ Relebactam in Complicated Infections: A Meta-analysis
- Comments on the Published MetaAnalysis of Clinical and Microbiologic Efficacy and Safety of Imipenem/ Cilastatin/Relebactam in Complicated Infections
- Comparison of Efficacy of Cefoperazone/Sulbactam and Imipenem/Cilastatin for Treatment of Acinetobacter Bacteremia
- Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients
- Multidrug-resistant bacteria: a national challenge requiring urgent addressal
